News Archive

The United States ranks 1st in how its domestic policies support worldwide life sciences innovation, according to an analysis released today by the Information Technology and Innovation Foundation (ITIF), a global technology policy think tank. Released on World Health Day, the findings come in a new report assessing 56 countries—which together comprise close to 90 percent of the world’s economy—on the extent to which their scientific research, drug pricing, and intellectual property policies contribute to global biopharmaceutical innovation.

U.S. R&D investment currently accounts for 2.7% of GDP, according to the newest R&D Funding Report put out by AAAS. While the United States still invests the most dollars into R&D globally, there has been a huge uptick in investments among Asian countries. China aims to invest 2.5% of its GDP in R&D by 2020 and is also expected to catch the U.S. in real dollars invested in R&D by 2020 as well.

The United States ranks 1st in how its domestic policies support worldwide life sciences innovation, according to an analysis released today by the Information Technology and Innovation Foundation (ITIF), a global technology policy think tank. Released on World Health Day, the findings come in a new report assessing 56 countries—which together comprise close to 90 percent of the world’s economy—on the extent to which their scientific research, drug pricing, and intellectual property policies contribute to global biopharmaceutical innovation.

Eight seed accelerators — 500 Startups, Alchemist, Amplify LA, Angelpad, Chicago New Venture Challenge, MuckerLab, Techstars and Y Combinator — landed the coveted top spots in the 2016 annual Seed Accelerator Rankings announced today at South by Southwest (SXSW) by entrepreneurship and management experts from Rice University, MIT and the University of Richmond.

Group urges state support of next phase of pharmaceutical industry’s focus and growth

More often than not, when talk in New Jersey turns to the pharmaceutical industry tones turn serious and the discussion centers around whether pharma will continue to support the state’s economy in the way it has for more than a century.

Ted Leonsis is teaming up with Georgetown University to start the Leonsis Family Entrepreneurship Prize, seeded with a $1 million cash gift. Who can compete? Georgetown students and recent alumni with great business ideas.

The health care-focused accelerator Dreamit Health will no longer operate in Baltimore and Johns Hopkins University is launching a new accelerator in its place.

GSK will be hosting a career fair at the GSK US R&D Centre at 14200 Shady Grove Road, Rockville, MD 20850.

On Thursday, April 14, 2016 from 11:00 AM to 3:00 PM senior leaders and recruiters will be on site at GSK Rockville, MD to get to know you and your career aspirations.

GSK is proud to be an employer that seeks to attract and retain the most talented individuals and encourage you to visit their event portal to create your profile in order to connect with them at this event.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and MedImmune, the global biologics research and development arm of AstraZeneca (LSE: AZN, SSE: AZN, NYSE: AZN), today announced that they have entered into a licensing agreement under which Regeneron will use MedImmune’s pyrrolobenzodiazepine (PBD)-based warhead and linker technology to produce antibody- drug conjugates (ADCs) as potential cancer treatments.

Tests on a drug with the potential to stop Alzheimer’s in its tracks are being funded by raffles, pensioners’ donations and a sponsored walk – because the research team cannot find money for pre-clinical safety tests any other way.